Lindsay Hughes has joined Ruder Finn as executive VP of its New York healthcare practice.
She spent 17 years at imre, exiting in March as executive VP-client experience.
Hughes has done brand reputation management, marketing and executive communications work for companies such as Johnson & Johnson, GlaxoSmithKline, AstraZeneca and Bristol Myers Squibb.
She will report to Christie Anbar, managing director of RF’s healthcare practice.
Ruder Finn is No. 5 in O’Dwyer’s rankings of healthcare firms with 2021 fees of $45M.
Imre holds the No. 8 slot with $34.8M in fees.